Michael Messinger - 09 Dec 2025 Form 4 Insider Report for SeaStar Medical Holding Corp (ICU)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
11 Dec 2025, 18:49:59 UTC
Prior SEC filing
08 Dec 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Michael Messinger

Key filing fact

Michael Messinger filed Form 4 for SeaStar Medical Holding Corp (ICU) on 11 Dec 2025.

Key facts

  • This page summarizes Michael Messinger's Form 4 filing for SeaStar Medical Holding Corp (ICU).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 11 Dec 2025, 18:49.

Change

  • Previous filing in this sequence was filed on 08 Dec 2025.
  • Current net transaction value: +$5,098.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001615039 Primary reporting owner

Messinger Michael

Relationship
Chief Financial Officer
Address
3513 BRIGHTON BLVD, SUITE 410, DENVER, UNITED ARAB EMIRATES
Signature
/s/ Michael Messinger
Signature date
11 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ICU transaction

Common Stock

Purchase

Transaction value
$5,098
Shares
+14,500
Change %
+483%
Price
$0.3516
Shares after
17,500
Date
09 Dec 2025
Ownership
Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .